School of Medicine
Showing 1,161-1,180 of 5,035 Results
-
John Eaton
Charles Lee Powell Foundation Professor in the School of Engineering, Emeritus
BioEaton uses experiments and computational simulations to study the flow and heat transfer in complex turbulent flows, especially those relevant to turbomachinery, particle-laden flows, and separated flows, and to develop new techniques for precise control of gas and surface temperature during manufacturing processes.
-
Noelle Hanako Ebel
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsCurrent projects include:
-indications for combined heart-liver transplantation
-mitigating perioperative bleeding during cardiac surgery in children with Alagille syndrome
-congenital heart disease and liver transplantation
-subspecialty advocacy -
Asiri Ediriwickrema MD, PhD
Assistant Professor of Medicine (Hematology)
BioAsiri Ediriwickrema, MD, PhD, is a physician-scientist who leads a systems hematology laboratory at Stanford and directs a clinical practice focused on myelodysplastic neoplasms and clonal hematopoiesis. Our research group studies hematopoiesis—the complex process by which hematopoietic stem cells generate the diverse blood cells essential for health throughout life. Our mission is to understand how individual blood cells change during aging and cancer development, with particular focus on how dysregulation of this process leads to cytopenias and hematologic malignancies.
We integrate expertise spanning clinical medicine, functional hematology, molecular and cellular biology, genomics, bioinformatics, and machine learning. By combining advanced experimental techniques with computational approaches, we examine blood cell development and function at single-cell resolution. Our work aims to identify the earliest cellular changes in cancer development, map how stem cells interact within their tissue environments, and develop AI-powered tools that predict stem cell behavior and disease progression. Our goal is to translate these efforts into improved diagnostics and precision therapeutic strategies for patients with blood disorders and malignancies.
Dr. Ediriwickrema earned his undergraduate degree in Engineering from the Massachusetts Institute of Technology, his MD (Cum Laude) from Yale University, and his PhD from Stanford University. He completed his residency in Internal Medicine and fellowship in Hematology at Stanford, where he also conducted his doctoral and postdoctoral research in the laboratory of Dr. Ravi Majeti. His research identified novel populations of multipotent progenitor cells in normal hematopoiesis and leukemia stem cells in acute myeloid leukemia (AML). -
Zachary Edmonds, MD, MBA
Academic Staff - Hourly - CSL, Medicine - Cardiovascular Medicine
Adjunct Professor, Medicine - Cardiovascular MedicineBioAdjunct Professor of Medicine | Cardiovascular Medicine | Stanford Medicine
Seasoned clinician with a proven track record of mentoring medtech entrepreneurs and early stage companies in the development of life changing technologies. As the Associate Director of the PAMF Hospital Medicine service line he co-leads a team of 30 physicians across 3 community hospitals in the Bay Area. When not seeing patients, he serves as the Chief Medical Officer at Fogarty Innovation where he mentors a variety of early stage companies. As an Adjunct Professor of Medicine at Stanford he works closely with the Biodesign group to teach and mentor students and Biodesign fellows. He co-teaches the Biodesign Innovation graduate course which is offered to Stanford graduate students in the school of medicine, school of engineering and the graduate school of business each winter and spring quarter. Zach holds an MD from the UCLA School of Medicine and an MBA from the UCLA Anderson School of Management. He completed Internal Medicine Residency and the Biodesign Fellowship at Stanford University. -
Katharine Sears Edwards
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor (By courtesy), Psychiatry and Behavioral SciencesCurrent Research and Scholarly InterestsPotential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.
Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).
Assessment and training in evidence-based psychological therapies. -
Matthew L. Edwards
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioMatthew Edwards is a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. In this role, Matthew also serves as the assistant director of residency training for the general adult psychiatry residency program. His clinical interests are in community and forensic psychiatry and his research interests lie at the intersection of medical history, ethics, and public policy.
Dr. Edwards graduated from Princeton University in 2010 with a degree in Sociology, magna cum laude, and received a graduate certificate in public health from the University of Texas School of Public Health in 2012. He received his MD, summa cum laude, with honors in research from the University of Texas Medical Branch School of Medicine in 2017. He completed his residency training in adult psychiatry at Stanford University School of Medicine in 2021 and his fellowship in forensic psychiatry at Emory University School of Medicine in 2022. He was a Pearce Fellow in the History of Medicine at the Clendening Library of the University of Kansas Medical Center in 2015.
His clinical interests are in community psychiatry and forensic psychiatry. At Stanford, Dr. Edwards treats patients in the division of adult psychiatry and the centerspace clinic. This recovery-oriented clinic provides culturally-contextualized and trauma-informed care for people with marginalized, multiple, and intersecting identities. He teaches the history of psychiatry to general psychiatry residents and forensic psychiatry fellows. Dr. Edwards regularly speaks about race, trauma, structural inequality, and the history of medicine at conferences and invited lectures. -
Bradley Efron
Max H. Stein Professor and Professor of Statistics and of Biomedical Data Science, Emeritus
Current Research and Scholarly InterestsResearch Interests:
BOOTSTRAP
BIOSTATISTICS
BAYESIAN STATISTICS -
Elizabeth Egan
Associate Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMalaria is a parasitic disease transmitted by mosquitos that is a leading cause of childhood mortality globally. Public health efforts to control malaria have historically been hampered by the rapid development of drug resistance. The goal of our research is to understand the molecular determinants of critical host-pathogen interactions in malaria, with a focus on the erythrocyte host cell. Our long-term goal is to develop novel approaches to prevent or treat malaria and improve child health.
-
Peter R. Egbert, MD
Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsOcular pathology of shaken baby syndrome
-
Karen Eggleston
Senior Fellow at the Freeman Spogli Institute for International Studies and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsHealth reform in China; comparative healthcare systems in Asia; government and market roles in the health sector; payment incentives; healthcare productivity; and economic implications of demographic change.
-
Goar Egoryan
Clinical Assistant Professor, Medicine
BioI am a Clinical Assistant Professor and oncology hospitalist in the Division of Hospital Medicine at Stanford University School of Medicine. I care for patients with solid tumors admitted with complex, high-acuity conditions, including cancer-related complications, treatment toxicities, infections, malnutrition, and end-of-life care, making complex clinical decisions and navigating high-stakes situations with patients and families, often integrating input from multiple consulting teams.
I received my Doctor of Medicine degree summa cum laude from Novosibirsk State Medical University and completed a two-year rheumatology fellowship in Russia, a specialty defined by multiorgan complexity and the search for systemic connections. I later moved to the United States, where I completed an internal medicine residency at Ascension Saint Francis Hospital in Evanston, IL. During residency, I was named Intern of the Year, received the Great Catch Award for identifying and correcting a patient care error, served as Chief Resident in my third year, and contributed to over 20 publications, half as first author.
My early training in rheumatology, a field centered on systemic disease and pattern recognition, continues to shape how I approach complex illness and informs my interest in integrative medicine. In my current practice, I already incorporate elements of integrative medicine by considering lifestyle, behavioral, and psychosocial factors alongside medical management when caring for complex patients. My current academic interest centers on bringing evidence-based integrative medicine into the inpatient oncology setting. I was recently awarded a Stanford SMART-HM grant to pursue formal training in integrative medicine and to develop a care model that addresses the needs of hospitalized oncology patients beyond disease-directed treatment, including symptom burden and psychological distress. My long-term aim is to expand this approach to broader hospitalized populations while improving patient experience and clinical outcomes. -
Shirit Einav
Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsOur basic research program focuses on understanding the roles of virus-host interactions in viral infection and disease pathogenesis. This program is combined with translational efforts to apply this knowledge for the development of broad-spectrum host-centered antiviral approaches to combat emerging viral infections, including dengue, encephalitic alphaviruses, coronaviruses, and filoviruses, and means to predict disease progression.
